STABILITY AND PROTEOLYTIC DOMAINS OF NEF PROTEIN FROM HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1

被引:41
作者
FREUND, J
KELLNER, R
HOUTHAEVE, T
KALBITZER, HR
机构
[1] MAX PLANCK INST MED RES,BIOPHYS ABT,D-69028 HEIDELBERG,GERMANY
[2] EUROPEAN MOLEC BIOL LAB,PEPTIDE & PROT GRP,HEIDELBERG,GERMANY
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1994年 / 221卷 / 02期
关键词
D O I
10.1111/j.1432-1033.1994.tb18795.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Proteolytic experiments in conjunction with H-1-NMR spectroscopy show that the Nef (negative factor) protein from human immunodeficiency virus type 1 probably consists of two main domains, the N-terminal anchor domain at amino acid positions 2-65 and the C-terminal core domain at positions 66-206. The N-terminal domain is likely to be located at the surface of the protein, while the C-terminal domain has a compactly folded core and is stable in the absence of the anchor domain. It is conceivable that the core domain represents a functional domain of the Nef protein, activated after the removal of the membrane anchor by the human-immunodeficiency-virus protease or cellular proteases. Nef is stable at pH 5-12 and denatures at 317-322 K. The Nef protein remains in its native conformation in dimethyl-sulfoxide/water mixtures up to 35% (by vol.), and in acetonitrile/water up to 14% (by vol.). Nef refolds spontaneously after denaturation with urea or guanidinium hydrochloride. The H-1-NMR parameters and pK(a) values of five of the nine histidine residues and one of the seven tyrosine residues were determined and were found in four cases to be typical for residues which are not located in the interior of the protein.
引用
收藏
页码:811 / 819
页数:9
相关论文
共 37 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[2]   A NEW HTLV-III LAV ENCODED ANTIGEN DETECTED BY ANTIBODIES FROM AIDS PATIENTS [J].
ALLAN, JS ;
COLIGAN, JE ;
LEE, TH ;
MCLANE, MF ;
KANKI, PJ ;
GROOPMAN, JE ;
ESSEX, M .
SCIENCE, 1985, 230 (4727) :810-813
[3]   THE HIV-1 NEF PROTEIN DOES NOT HAVE GUANINE-NUCLEOTIDE BINDING, GTPASE, OR AUTOPHOSPHORYLATING ACTIVITIES [J].
BACKER, JM ;
MENDOLA, CE ;
FAIRHURST, JL ;
KOVESDI, I .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (12) :1015-1020
[4]   PREDICTING CLEAVABILITY OF PEPTIDE SEQUENCES BY HIV PROTEASE VIA CORRELATION-ANGLE APPROACH [J].
CHOU, JJ .
JOURNAL OF PROTEIN CHEMISTRY, 1993, 12 (03) :291-302
[5]   INFECTIOUS MUTANTS OF HTLV-III WITH CHANGES IN THE 3' REGION AND MARKEDLY REDUCED CYTOPATHIC EFFECTS [J].
FISHER, AG ;
RATNER, L ;
MITSUYA, H ;
MARSELLE, LM ;
HARPER, ME ;
BRODER, S ;
GALLO, RC ;
WONGSTAAL, F .
SCIENCE, 1986, 233 (4764) :655-659
[6]  
FRANCKI RIB, 1991, ARCH VIROL S, V2, P290
[7]  
GELDERBLOM HR, 1993, AIDS FORSCH, V5, P231
[8]   FURTHER DEVELOPMENTS OF PROTEIN SECONDARY STRUCTURE PREDICTION USING INFORMATION-THEORY - NEW PARAMETERS AND CONSIDERATION OF RESIDUE PAIRS [J].
GIBRAT, JF ;
GARNIER, J ;
ROBSON, B .
JOURNAL OF MOLECULAR BIOLOGY, 1987, 198 (03) :425-443
[9]   ON THE COMPOSITION OF THE CYTOSOL OF RELAXED SKELETAL-MUSCLE OF THE FROG [J].
GODT, RE ;
MAUGHAN, DW .
AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 254 (05) :C591-C604
[10]   ANTIGENIC EPITOPES OF NEF PROTEINS FROM DIFFERENT HIV-1 STRAINS AS RECOGNIZED BY SERA FROM PATIENTS WITH MANIFEST AND LATENT HIV-INFECTION [J].
GOMBERT, FO ;
BLECHA, W ;
TAHTINEN, M ;
RANKI, A ;
PFEIFER, S ;
TROGER, W ;
BRAUN, R ;
MULLERLANTZSCH, N ;
JUNG, G ;
RUBSAMENWAIGMANN, H ;
KROHN, K .
VIROLOGY, 1990, 176 (02) :458-466